Cargando…
Metabolic engineering of probiotic Escherichia coli for cytolytic therapy of tumors
Bacterial cancer therapy was developed using probiotic Escherichia coli Nissle 1917 (EcN) for medical intervention of colorectal cancer. EcN was armed with HlyE, a small cytotoxic protein, under the control of the araBAD promoter (P(BAD)). The intrinsic limitation of P(BAD) for the gene expression i...
Autores principales: | Chiang, Chung-Jen, Huang, Po-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971005/ https://www.ncbi.nlm.nih.gov/pubmed/33712706 http://dx.doi.org/10.1038/s41598-021-85372-6 |
Ejemplares similares
-
In situ delivery of biobutyrate by probiotic Escherichia coli for cancer therapy
por: Chiang, Chung-Jen, et al.
Publicado: (2021) -
Metabolic engineering of Escherichia coli for production of n-butanol from crude glycerol
por: Saini, Mukesh, et al.
Publicado: (2017) -
Systematic engineering of the central metabolism in Escherichia coli for effective production of n-butanol
por: Saini, Mukesh, et al.
Publicado: (2016) -
Human MAIT cell cytolytic effector proteins synergize to overcome carbapenem resistance in Escherichia coli
por: Boulouis, Caroline, et al.
Publicado: (2020) -
Production of salidroside in metabolically engineered Escherichia coli
por: Bai, Yanfen, et al.
Publicado: (2014)